Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
AstraZeneca
Fish and Richardson
Mallinckrodt
Farmers Insurance
Argus Health
Deloitte
Medtronic
Express Scripts
McKesson

Generated: October 23, 2017

DrugPatentWatch Database Preview

Details for Patent: 7,259,186

« Back to Dashboard

Which drugs does patent 7,259,186 protect, and when does it expire?


Patent 7,259,186 protects TRILIPIX and is included in one NDA. There have been two Paragraph IV challenges on Trilipix.

This patent has nineteen patent family members in eleven countries.

Summary for Patent: 7,259,186

Title:Salts of fenofibric acid and pharmaceutical formulations thereof
Abstract:In one aspect, the present invention relates to a formulation in the form of molecular dispersion comprising i) fenofibric acid, a physiologically acceptable salt or derivative thereof and optionally other active substances, ii) a binder component comprising at least one enteric binder, and optionally iii) other physiologically acceptable excipients.In a second aspect, the present invention relates to novel salts of fenofibric acid that are photostable when compared to other salts of fenofibric acid.
Inventor(s): Cink; Russell Drew (Grayslake, IL), Paterson, Jr.; Joseph B. (Vernon Hills, IL), Gao; Yi (Vernon Hills, IL), Zhang; Geoff G. Z. (Libertyville, IL), Long; Michelle A. (Libertyville, IL), Morris; John B. (Grayslake, IL), Rosenberg; Joerg (Ellerstadt, DE)
Assignee: Abbott Laboratories (Abbott Park, IL)
Application Number:10/880,851
Patent Claim Types:
see list of patent claims
Compound; Composition; Formulation;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Abbvie
TRILIPIX
choline fenofibrate
CAPSULE, DELAYED RELEASE;ORAL022224-001Dec 15, 2008ABRXYesNo► Subscribe► SubscribeY
Abbvie
TRILIPIX
choline fenofibrate
CAPSULE, DELAYED RELEASE;ORAL022224-002Dec 15, 2008ABRXYesYes► Subscribe► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: 7,259,186

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria359777► Subscribe
Australia2003290060► Subscribe
Australia2010249244► Subscribe
Canada2510261► Subscribe
China100473378► Subscribe
China101480384► Subscribe
China1726024► Subscribe
Germany60313359► Subscribe
European Patent Office1572190► Subscribe
European Patent Office1829541► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Teva
Cipla
Covington
McKesson
Julphar
Fuji
Chubb
McKinsey
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot